Laboratory screening revealed anemia, with a low hematocrit level in 33.3% (4/12), hyponatremia and hypokalemia in 66.6% (8/12), raised urea and creatinine levels in 25% (3/12), elevated ALT and AST in 75% (9/12), and a low thyroid-stimulating hormone (TSH) level in 91.6% (11/12). This evidence concerns the gene GPT and anemia.